CHUV
Les activités du CHUV
MENU
Service de gastro-entérologie
et d’hépatologie
Accueil > Recherche > Publications > 2013

Publications


Articles originaux et de revue


2013

1: Aouri M, Moradpour D, Cavassini M, Mercier, T, Buclin T, Csajka C, Telenti A, Rauch A, Decosterd LA
    A multiplex LC MS/MS assay for the simultaneous therapeutic drug monitoring of ribavirin, boceprevir and telaprevir.
Antimicrob Agents Chemother. 2013 Jul;57(7):3147-58.
2: Bersier M, Pache I.
    Wilson's disease: programmed wandering?
Rev Med Suisse 2013;9:384-385.
3: Bibert S, Roger T, Calandra T, Bochud M, Cerny A, Semmo N, Duong FHT, Gerlach T, Malinverni R, Moradpour D, Negro F, Müllhaupt B, Bochud P-Y, and the Swiss Hepatitis C Cohort Study.
    IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction.
J Exp Med. 2013 Jun 3;210(6):1109-16
4: Brounais-Le Royer B, Pierroz DD, Velin D, Frossard C, Zheng XX, Lehr HA, Ferrari-Lacraz S, Ferrari SL.
    Effects of an Interleukin-15 Antagonist on Systemic and Skeletal Alterations in Mice with DSS-Induced Colitis.
Am J Pathol. 2013 Jun;182(6):2155-67
5: Burgmann K, Fatio S, Jordi B, Rutishauser J.
    Medical care of type 2 diabetes mellitus in light of international and national recommendations: a retrosprective analysis.
Swiss Med Wkly 2013;143:w13871
6: Buyse S, Roque-Afonso AM, Vaghefi P, Gigou M, Dussaix E, Duclos-Vallée JC, Samuel D, Guettier C
    Acute hepatitis with periportal confluent necrosis associated with human herpesvirus 6 infection in liver transplant patients.
Am J Clin Pathol 2013;140:403-409
7: Clayton H, Flatz L, Vollenweider-Roten S, Schoepfer A, Gilliet M, Conrad C
    Anti-TNF therapy in the treatment of psoriasis in a patient with acute-on-chronic pancreatitis.
Dermatology 2013;227:193-196
8: D'Angelo F, Bernasconi E, Schäfer M, Moyat M, Michetti P, Maillard MH, Velin D.
    Macrophages promote epithelial repair through hepatocyte growth factor secretion.
Clin Exp Immunol. 2013 Jun 18.
9: Daniele G, Costa N, Lorusso V, Costa-Maia J, Pache I, Pirisi M.
    Methodological assessment of HCC literature.
Ann Oncol 2013;24 Suppl 2:ii6-14
10: De Vos M, De Vroey B, Garcia Garcia B, Roy C, Kidd F, Henrion J, Deltenre P
    The role of proton pump inhibitors in the occurrence and prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Liver Int 2013;33:1316-1323
11: De Vroey B, Moreno C, Laleman W, van Gossum M, Colle I, de Galocsy C, Langlet P, Robaeys G, Orlent H, Michielsen P, Delwaide J, Reynaert H, D’Heygere F, Sprengers D, Bourgeois S, Assene C, Vos B, Brenard R, Adler M, Henrion J, Deltenre P.
    HBV and HCV infections in Belgium: similarities and differences in epidemics and in initial management.
Eur J Gastroenterol Hepatol 2013;25:613-619
12: Esser-Nobis K, Romero-Brey I, Ganten TM, Gouttenoire J, Harak C, Klein R, Schemmer P, Binder M, Schnitzler P, Moradpour D, Bartenschlager R, Polyak SJ, Stremmel W, Penin F, Eisenbach C, Lohmann V.
    Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B
Hepatology. 2013 Mar;57(3):953-63.
13: Fraga M, Doerig C, Dorta G, Nichita C.
    Radiofrequency ablation for Barret's esophagus.
Rev Med Suisse 2013;9:1572-1576
14: Fretz R, Negro F, Bruggmann P, Lavanchy D, De Gottardi A, Pache I, Masserey Spicher V, Cerny A.
    Hepatitis B and C in Switzerland – healthcare provider initiated testing for chronic hepatitis B and C infection.
Swiss Med Wkly 201317;143:w13793
15: Godat S, Velin D, Aubert V, Nydegger A, Schoepfer AM, Maillard MH.
    An update on celiac disease.
Rev Med Suisse 2013;9:1584-1589
16: Hiroz P, Gouttenoire J, Dao Thi VL, Sahli R, Telenti A, Moradpour D, Doerig C.
    Mise à jour sur l'hépatite E.
Rev Med Suisse 2013;9:1594-1598
17: Ho E, Deltenre P, Nkuize M, Delwaide J, Colle I, Michielsen P
    Coinfection of hepatitis B and hepatitis delta virus in Belgium: a multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection.
J Med Virol 2013;85:1513-1517
18: Lange CM, Bibert S, Dufour JF, Cellerai C, Cerny A, Heim MH, Kaiser L, Malinverni R, Müllhaupt B, Negro F, Semela D, Moradpour D, Kutalik Z, Bochud PY, and the Swiss Hepatitis C Cohort Study Group.
    Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma.
J Hepatol. 2013 Sep;59(3):504-9.
19: Lange CM, Miki D, Ochi H, Nischalke H-D, Bojunga J, Bibert S, Morikawa K, Gouttenoire J, Cerny A, Dufour JF, Gorgievski-Hrisoho M, Heim MH, Malinverni R, Müllhaupt B, Negro F, Semela D, Kutalik Z, Müller T, Spengler U, Berg T, Chayama K, Moradpour D, Bochud PY, the Hiroshima Liver Study Group, and the Swiss Hepatitis C Cohort Study Group.
    Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development.
PLoS One. 2013 May 29;8(5):e64053.
20: Müllhaupt B and Moradpour D.
    Schlaglicht Hepatologie: Wichtiges zur chronischen Hepatitis C.
Schweiz Med Forum 2013;13:28-30
21: Moradpour D and Frossard J-L
    Progrès et nouveaux défis dans l'hépatite C [Editorial].
Rev Med Suisse 2013;9:1563-1564
22: Moradpour D and Penin F.
    Hepatitis C virus proteins: from structure to function.
Curr Top Microbiol Immunol. 2013;369:113-42.
23: Moradpour D und Blum HE.
    Ikterus. In: Siegenthalers Differenzialdiagnose. Innere Krankheiten - vom Symptom zur Diagnose.
Battegay E, Hrsg. 20. Auflage. Georg Thieme Verlag, Stuttgart - New York, 2013, pp. 752-791
24: Moradpour D und Blum HE.
    Schmerzen im Bereich des Abdomens. In: Siegenthalers Differenzialdiagnose. Innere Krankheiten - vom Symptom zur Diagnose.
Battegay E, Hrsg. 20. Auflage. Georg Thieme Verlag, Stuttgart - New York, 2013, pp. 272-317.
25: Pedersen N, Bortoli A, Duricova D, D Inca R, Panelli MR, Gisbert JP, Zoli G, López-Sanromán A, Castiglione F, Riegler G, Annese V, Gionchetti P, Prada A, Pont ED, Timmer A, Felley C, Shuhaibar M, Tsianos EV, Dejaco C, Baert FJ, Jess T, Lebech M, Hommes DW, Munkholm P; European Crohn-Colitis Organisation – ECCO Study Group of Epidemiology Committee - EpiCom.
    The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women.
Aliment Pharmacol Ther 2013;38:501-512
26: Perreau M, Rozot V, Welles HC, Belluti-Enders F, Vigano S, Maillard M, Dorta G, Mazza-Stalder J, Bart PA, Roger T, Calandra T, Nicod L, Harari A
    Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active disease.
Eur J Immunol. 2013 Apr;43(4):939-48.
27: Pittet V, Froehlich F, Maillard MH, Mottet C, Gonvers JJ, Felley C, Vader JP, Burnand B, Michetti P, Schoepfer A; the EPACT-II Update Panellists.
    When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel.
J Crohns Colitis. 2013 May 9. pii: S1873-9946(13)00167-0.
28: Pittet V, Rogler G, Michetti P, Fournier N, Vader JP, Schoepfer A, Mottet C, Burnand B, Froehlich F; Swiss Inflammatory Bowel Disease Cohort Study Group.
    Penetrating or stricturing diseases are the major determinants of time to first and repeat resection surgery in Crohn's disease.
Digestion. 2013;87(3):212-21. doi: 10.1159/000350954.
29: Quarato G, Scrima R, Agriesti F, Moradpour D, Capitanio N, Piccoli C.
    Targeting mitochondria in the infection strategy of the hepatitis C virus.
Int J Biochem Cell Biol. 2013 Jan;45(1):156-66
30: Rau M, Stickel F, Russmann S, Manser C, Becker P, Weisskopf M, Schmitt J, Dill MT, Dufour JF, Moradpour D, Semela D, Müllhaupt B, Geier A
    Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with hepatitis C virus infection.
J Hepatol. 2013 Apr;58(4):669-75.
31: Reinisch W, Chowers Y, Danese S, Dignass A, Gomollón F, Nielsen OH, Lakatos PL, Lees CW, Lindgren S, Lukas M, Mantzaris GJ, Michetti P, Moum B, Peyrin-Biroulet L, Toruner M, van der Woude J, Weiss G, Stoevelaar H.
    The management of iron deficiency in inflammatory bowel disease--an online tool developed by the RAND/UCLA appropriateness method.
Aliment Pharmacol Ther 2013;38:1109-1118
32: Rogler G, Aldeguer X, Kruis W, Lasson A, Mittmann U, Nally K, Peyrin-Biroulet L, Schoepfer A, Vatn M, Vavricka S, Logan R.
    Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: Expert clinical opinion.
J Crohns Colitis. 2013 Sep 1;7(8):670-7
33: Rogler G, Vavricka S, Schoepfer A, Lakatos PL
    Mucosal healing and deep remission: what does it mean?
World J Gastroenterol 2013;19:7552-7560
34: Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A; GEMINI 2 Study Group.
    Vedolizumab as induction and maintenance therapy for Crohn's disease.
N Engl J Med. 2013;369:711-721
35: Schaffer T, Flogerzi B, Schoepfer AM, Seibold F, Müller S.
    Increased titers of anti-Saccharomyces cerevisiae antibodies in Crohn’s disease patients with reduced H-ficolin levels but normal MASP-2 activity.
J Crohns Colitis 2013;7:e1-10
36: Schnegg A, Bürgisser P, André C, Kenfak-Foguena A, Canellini G, Moradpour D, Abravanel F, Izopet J, Cavassini M, Darling KEA.
    An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population.
PLoS One. 2013 May 7;8(5):e62980.
37: Schoepfer AM, Beglinger C, Straumann A, Safroneeva E, Romero Y, Armstrong D, Schmidt C, Trummler M, Pittet V, Vavricka SR.
    Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.
Inflamm Bowel Dis. 2013 Feb;19(2):332-41.
38: Schoepfer AM, Dehlavi MA, Fournier N, Safroneeva E, Straumann A, Pittet V, Peyrin-Biroulet L, Michetti P, Rogler G, Vavricka SR.
    Diagnostic Delay in Crohn's Disease Is Associated With a Complicated Disease Course and Increased Operation Rate.
Am J Gastroenterol. 2013 Aug 27.
39: Schoepfer AM, Safroneeva E, Bussmann C, Kuchen T, Portmann S, Simon HU, Straumann A.
    Delay in Diagnosis of Eosinophilic Esophagitis Increases Risk for Stricture Formation, in a Time-Dependent Manner
Gastroenterology. 2013 Aug 13.
40: Siebert U, Wurm J, Gothe RM, Arvandi M, Vavricka SR, von Känel R, Begré S, Sulz MC, Meyenberger C, Sagmeister M; Swiss IBD Cohort Study Group.
    Predictors of temporary and permanent work disability in patients with inflammatory bowel disease: results of the swiss inflammatory bowel disease cohort study.
Inflamm Bowel Dis. 2013 Mar-Apr;19(4):847-55.
41: Stickel F, Worni M, Pache I, Moradpour D, Helbling B, Borovicka J, Kummer O, Gerlach TJ.
    Optimising ribavirin exposure by therapeutic drug monitoring improves treatment response in patients with chronic hepatitis C genotype 1.
Am J Gastroenterol. 2013 Jul;108(7):1176-8.
42: Sulz MC, Siebert U, Arvandi M, Gothe RM, Wurm J, von Känel R, Vavricka SR, Meyenberger C, Sagmeister M; Swiss IBD Cohort Study Group.
    Predictors for hospitalization and outpatient visits in patients with inflammatory bowel disease: results from the Swiss Inflammatory Bowel Disease Cohort Study.
Eur J Gastroenterol Hepatol 2013;25:790-797
43: Trépo E, Ouziel R, Pradat P, Momozawa Y, Quertinmont E, Gervy C, Gustot T, Degré D, Vercruysse V, Deltenre P, Gulbis B, Franchimont D, Devière J, Lemmers A, Moreno C.
    Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.
J Hepatol 2013;59:344-350
44: Vavricka SR, Manser CN, Hediger S, Vögelin M, Scharl M, Biedermann L, Rogler S, Seibold F, Sanderink R, Attin T, Schoepfer A, Fried M, Rogler G, Frei P.
    Periodontitis and gingivitis in inflammatory bowel disease: a case-control study.
Bowel Dis 2013;19:2768-2777
45: Vavricka SR, Schoepfer AM, Safroneeva E, Rogler G, Schwenkglenks M, Achermann R.
    A shift from oral to intravenous iron supplementation therapy is observed over time in a large swiss cohort of patients with inflammatory bowel disease.
Inflamm Bowel Dis. 2013 Mar-Apr;19(4):840-6.
46: Vionnet J, Petitpierre S, Fumeaux A, Meuli R, Spertini F, Comte D.
    Allergy to radiographic contrast media.
Rev Med Suisse 2013;9; 812-818
47: Windsor A, Michetti P, Bemelman W, Ghosh S.
    The positioning of colectomy in the treatment of ulcerative colitis in the era of biologic therapy.
Inflamm Bowel Dis 2013;19:2695-2703